In a survey of 377 buprenorphine prescribers in Michigan, high-threshold practices such as requiring counseling as a condition for buprenorphine treatment and conducting drug testing during every in-office visit were associated with higher rates of treatment termination for patients receiving buprenorphine. Buprenorphine treatment continuity is critical to preventing overdose deaths amidst an intensifying national overdose crisis. State policy reforms encouraging practices to retain patients in treatment even if they do not strictly adhere to counseling recommendations and limiting drug testing to a clinically relevant frequency could improve overall patient engagement with buprenorphine treatment and save lives.
Published January 16, 2024
Sign up to receive our monthly Research Roundup email, which offers a selection of new public health research from major journals.
Recent Abstracts
Information About New Federal Regulations for Opioid Treatment Programs (OTPs)
Centering Country Ownership and Leadership: The Data for Health Initiative’s Approach
Mass Media Campaigns
Data for Health: Advancing Gender Equity
The Index of Tobacco Control Sustainability
Index of Tobacco Control Sustainability (ITCS): India Subnational Tobacco Control
Index of Tobacco Control Sustainability (ITCS): Indonesia Subnational Tobacco Control
Considerations for Planning Childhood Blood Lead Surveillance
Air Quality Monitoring Toolkit: Assessing Second-Hand Smoke in Hospitality Venues
Tobacco Control Implementation and Enforcement